Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
ISCNF ISRACANN BIOSCIENCES INC
0.0320.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/02/28(Q2)2021/11/30(Q1)2021/08/31(FY)2021/05/31
Assets
Current assets
Cash, cash equivalents and short term investments
-86.59% 310.61K -59.12% 826.68K -57.61% 1.4M -49.67% 1.96M
-Cash and cash equivalents
-86.59% 310.61K -59.12% 826.68K -57.61% 1.4M -49.67% 1.96M
Receivables
-42.16% 183.7K 107.11% 229.62K -46.43% 237.29K -14.25% 208.26K
-Accounts receivable
-- 116.6K -- 105.25K -- 97.83K -- 81.72K
-Taxes receivable
-73.46% 67.1K 371.01% 124.37K -41.39% 139.46K -47.9% 126.54K
Prepaid assets
-7.23% 73.61K -7.35% 99.16K -86.61% 25.53K -53.35% 84.39K
Total current assets
-81.08% 567.93K -54.55% 1.16M -60.86% 1.66M -58.91% 2.25M
Non current assets
Net PPE
-33.72% 58.15K -29.65% 68.58K -26.32% 79.01K -23.59% 89.45K
-Gross PPE
6.61% 220.92K 6.61% 220.92K 6.61% 220.92K 6.61% 220.92K
-Accumulated depreciation
-36.21% -162.77K -38.81% -152.34K -41.91% -141.91K -45.81% -131.48K
Goodwill and other intangible assets
-- -- -- -- -- -- -- 0
Investments and advances
444.4% 1.43M 447.21% 1.47M 454.15% 1.48M -5.48% 254.39K
Long-term notes receivables
50.04% 720.04K 46.9% 717.95K 39.32% 677.41K 6.09% 520.26K
Non current accounts receivable
-- -- -- -- -- 30.79K -- 56.36K
Non current prepaid assets
-- 0 -- -- -- -- -5.48% 1.23M
Total non current assets
-90.3% 2.21M -90.14% 2.25M -90.05% 2.27M -90.57% 2.15M
Total assets
-89.23% 2.78M -86.58% 3.41M -85.46% 3.93M -84.44% 4.4M
Liabilities
Current liabilities
Payables
-- 483.84K -- -- -- -- -- --
-accounts payable
-- 483.84K -- -- -- -- -- --
Current accrued expenses
-- 264.04K -- -- -- -- -- --
Current liabilities
-32.97% 747.88K -19.56% 769.87K -61.91% 459.77K -72.93% 465.25K
Non current liabilities
Total non current liabilities
-- 0 -- 0 -- 0 -- 0
Total liabilities
-32.97% 747.88K -19.56% 769.87K -61.91% 459.77K -72.93% 465.25K
Shareholders'equity
Share capital
1.97% 62.01M 8.16% 62.01M 8.16% 62.01M 9% 62.01M
-common stock
1.97% 62.01M 8.16% 62.01M 8.16% 62.01M 9% 62.01M
Retained earnings
-46.93% -74.09M -59.58% -73.47M -62.57% -72.6M -64.73% -72.13M
Gains losses not affecting retained earnings
3.35% 14.12M 7.22% 14.1M 7.03% 14.06M 4.5% 14.06M
Total stockholders'equity
-91.76% 2.04M -89.19% 2.64M -86.55% 3.47M -85.17% 3.94M
Noncontrolling interests
0% -3.29K 0% -3.29K 0% -3.29K 0% -3.29K
Total equity
-91.77% 2.03M -89.2% 2.64M -86.56% 3.47M -85.18% 3.94M
Currency Unit
CADCADCADCAD
Audit Opinions
------Unqualified Opinion with Explanation

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Isracann Biosciences, Inc. is an Israeli-based cannabis company. It focuses on producing low-cost cannabis. The company was founded on January 21, 2010 and is headquartered in Vancouver, Canada.
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...